We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Here as of late... would like to hear some sort of update .
Some sort or update from the company would be nice... im still waiting for a placment rns to raise more cash
Think this one is dead in the water.
That's serious confidence korvet, god yea korvet that smacks of serious belief in a company. Yep must habe backed a winner then. Sure have scooby pass the scooby snacks lets celebrate we' re on a NASA trajectory
Over on the AD BB about our patient, (only one, though there was more) if anybody is out there or is it just little me on this side of the electronic divide. Lol.
showing up, good news expected?
What gives?
I think that was really a buy, wonder what is in the pipeline, the testing has started, is there some news on the horizon. If so can it please wait for a month until I cash in some winners from elsewhere and top up here. (I wish). Lol.
Wow 70k sold that must be why the bid dropped through the floor. Lol ðŸ˜
Wow This to be released on Tuesday http://www.intensitytherapeutics.com/pdf/2017%2005%2030%20Intensity%20Initiates%20clinical%20trial%20of%20INT230-6%20final.pdf
https://www.clinicaltrials.gov/ct2/show/NCT03058289?term=intensity+therapeutics&rank=1 sorry - wrong link!
http://www.lse.co.uk/ShareChat.asp?ShareTicker=SALV&share=salvarx_grp_plc Seen it now. Took a bit of digging though!
Where does it say that no results are expected until July 2018? I must have missed that bit. I would have thought it would be sooner than that.
Thanks Chazzy2 - So reading up on this then no results expected till July 2018
http://www.businesswire.com/news/home/20170404005049/en/Intensity-Therapeutics-Reports-INT230-6-Induces-Protective-T-Cell Good news that they are now recruiting for the trials.
The fact that the directors wanted to give their own cash injection whilst also boosting their own holdings, along with a couple of very astute acquisitions with huge potential, still didn't budge the price up much. MMs at play? IMO this gives everyone a second chance to buy - a more 'newsworthy' RNS and it should hit 40p again I reckon - forecasts are around 150p but I don't want to get carried away cos I know this is AIM!
I think we may be seeing the Jim Mellon effect today. SALV was one of his picks for going long at his Master Investor speech. Investors are taking notice.
That's a massive upside: Current Price: 29p; Target Price: 149p It's a 4bagger, potentially,. I need to get in IF it will hit 149p
Great to hear SALV presenting at the MI show today. It was a fairly short presentation of only 10 minutes but strongly reinforced the investment case. I didn't catch the name of the presenter (it wasn't Ian Walters unfortunately, who gave an excellent presentation last year) but he stated that SALV hopes to make some more investments this year, with the aim of phasing the investments so as to bring at least one drug to clinical trials each year. Huge market of $80 billion by 2020. Jim Mellon obviously a big fan still as he sat in the front row!
Not for too long hopefully.
That's why I bought in. Worldwide cherry picking, sound building of complementary biz, decent communication. Slowly and surely. Bottom drawer holding for me.
Thats good news, if they dont need a placing then this is going to rocket with a solid rns
$5 million should last long enough until there is sufficient human trial data to strike a deal with a big pharma.